Acute Human Immunodeficiency Virus Infection in Patients Presenting to an Urban Urgent Care Center

Clinical Infectious Diseases

Volumn 37, Issue 12, 2003, Pages 1699-1704

  Pincus, Jonathan M ^a,d   Crosby, Sondra S ^a   Losina, Elena ^b   King, Erin R ^a   LaBelle, Colleen ^a   Freedberg, Kenneth A ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ACUTE DISEASE; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; FLU LIKE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; RELIABILITY; URBAN POPULATION; VIRUS DETECTION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RNA, VIRAL;

EID: 0346218071     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379772     Document Type: Article

References (41)

1. HIV prevalence estimates and AIDS case projections for the United States: report based upon a workshop. MMWR Morb Mortal Wkly Rep 1990; 39(RR-16):1-31.
2. Tindall B, Baker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988; 148:945-9.
3. Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997; 278:2085-9.
4. Kahn JO, Walker BD. Current concepts: acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33-9.
5. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997; 24:965-70.
6. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257-64.
7. Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L. Biological and virologic characteristics of primary HIV infection. Ann Intern Med 1998; 128:613-20.
8. Kaufmann GR, Zaunders JJ, Cunningham P, et al. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection. AIDS 2000; 14:2643-51.
9. Lori F, lessen H, Lieberman J, et al. Treatment of human immunodeficiency virus with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis 1999; 180:1827-32.
10. Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-6.
11. + T cell responses associated with control of viremia. Science 1997; 278:1447-50.
12. Lisziewicz J, Rosenberg E, Liberman J, et al. Control of HIV despite the discontinuation of antiretroviral therapy [letter]. N Engl J Med 1999; 340:1683-4.
13. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS 2001; 15:77-85.
14. Sey K, Harawa N. High-risk behavior among individuals diagnosed with acute/primary or recent HIV infection [abstract 216]. In: Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, VA: Foundation for Retrovirology and Human Health, 2001. Available at: http://www.retro conference.org//2001/abstracts/abstracts/abstracts/216.htm.
15. Pinkerton SD, Abramson PR. Implications of increased infectivity in early-stage HIV infection: application of a Bernoulli-process model of HIV transmission. Eval Rev 1996; 20:516-40.
16. Cates W, Chesney MA, Cohen MS. Primary HIV infection - a public health opportunity. Am J Public Health 1997; 87:1928-30.
17. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:249-58.
18. Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection. Ann Intern Med 2001; 134:25-9.
19. Rich JD, Merriman NA, Mylonakis E, et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med 1999; 130:37-9.
20. Samet JH, Libman H, LaBelle C, et al. A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med 1995; 155:1629-33.
21. Hecht FM, Busch MP, Rawal B, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002; 16: 1119-29.
22. Lavreys L, Thompson ML, Martin HL, et al. Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis 2000; 30:486-90.
23. Chen Z, Branson B, Ballenger A, Peterman T. Risk assessment to improve targeting of HIV counseling and testing services of STD clinic patients. Sex Transm Dis 1998; 25:539-43.
24. Quinn T, Glasser D, Cannon R, et al. Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med 1988; 318:197-203.
25. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing and referral. MMWR Morb Mortal Wkly Rep 2001; 50(RR-19):1-57.
26. Centers for Disease Control and Prevention. Advancing HIV prevention: mew strategies for a changing epidemic - United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:329-32.
27. Freedberg KA, Samet JH. Think HIV: why physicians should lower their threshold for HIV testing. Arch Intern Med 1999; 159:1994-2000.
28. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins, 1996.
29. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, eds. SEER cancer statistics review, 1973-1996. Bethesda, MD: National Cancer Institute, 1999.
30. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112:594-642.
31. Eddy DM. Screening for breast cancer. Ann Intern Med 1989; 111: 389-99.
32. Busch MP, Satten GA. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am J Med 1997; 102:117-124.
33. Flanigan T, Tashima KT. Diagnosis of acute HIV infection: it's time to get moving [editorial]. Ann Intern Med 2001; 134:75-7.
34. Brambilla D, Granger S, Jennings C, Bremer J. Rates of false-positive results on quantitative HIV RNA assays [abstract 236]. In: Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections (Chicago). Alexandria, VA: Foundation for Retrovirology and Human Health, 2001.
35. Pilcher CD, McPherson JT, Leone PA, et al. Real-time universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA 2002; 288:216-21.
36. Walensky RP, Goldie SJ, Sax PE, et al. Treatment for primary HIV infection: projecting outcomes of immediate, interrupted or delayed therapy. J Acquir Immune Defic Syndr 2002; 31:27-37.
37. Centers for Disease Control and Prevention. Routinely recommended HIV testing at an urban urgent-care clinic - Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:538-41.
38. Walensky RP, Losina E, Steger-Craven KA, Freedberg KA. Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. Arch Intern Med 2002; 162:887-92.
39. Rosenberg E, Caliendo A, Walker B. Acute HIV infection among patients tested for mononucleosis [letter]. N Engl J Med 1999; 340:969.
40. Weber JT, Frey RL, Horsley R, Gwinn ML. Publicly funded HIV counseling and testing in the United States, 1992-1995. AIDS Educ Prev 1997; 9(Suppl 3):79-91.
41. HIV/AIDS Bureau and Bureau of Communicable Disease Control, Massachusetts Department of Public Health. Epidemiological profile FY' 2000: CDC cooperative agreement. Boston: Massachusetts Department of Public Health, 2000.